http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0065843-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 |
filingDate | 1982-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1985-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1985-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0065843-B1 |
titleOfInvention | New m-4 and iso m-4 derivatives, their preparation and compositions containing them |
abstract | Dihydro-M-4 and dihydro-IsoM-4 are new compounds which may be prepared by the catalytic hydrogenation of M-4 or IsoM-4 respectively. They, and their salts and esters (which may be prepared by conventional salification or esterification reactions with the parent dihydro-M-4 or dihydro-IsoM-4), are capable of inhibiting cholesterol biosynthesis in the liver and may be formulated, for therapeutic use, with conventional pharmaceutical carriers or diluents. |
priorityDate | 1981-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.